Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16440534 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
Condition: Asthma
Interventions: Drug: MK0476, montelukast sodium / Duration of Treatment: 4 weeks;   Drug: Comparator: placebo / Duration of Treatment: 4 weeks
2 Completed Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
Condition: Insomnia
Interventions: Drug: MK0928, gaboxadol;   Drug: Comparator: placebo

Indicates status has not been verified in more than two years